Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 800 shares, a decline of 92.5% from the April 30th total of 10,700 shares. Approximately 0.0% of the shares of the stock are short sold. Based […]
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Posts Quarterly Earnings Results, Misses Expectations By $0 41 EPS wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Performance NYSEAMERICAN ARMP opened at $3.91 on Friday. The company has a market cap of $141.35 million, […]
Armata Pharmaceuticals, Inc (NYSEAMERICAN:ARMP) Short Interest Up 688 3% in July wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Free Report) is scheduled to issue its quarterly earnings data on Wednesday, August 9th. Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Free Report) last posted its quarterly earnings data on Thursday, May 11th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.11). The […]